551 related articles for article (PubMed ID: 19304273)
1. Asbestos-induced lung diseases: an update.
Kamp DW
Transl Res; 2009 Apr; 153(4):143-52. PubMed ID: 19304273
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis.
Liu G; Beri R; Mueller A; Kamp DW
Chem Biol Interact; 2010 Nov; 188(2):309-18. PubMed ID: 20380827
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of asbestos-induced lung disease.
Liu G; Cheresh P; Kamp DW
Annu Rev Pathol; 2013 Jan; 8():161-87. PubMed ID: 23347351
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases.
Shukla A; Gulumian M; Hei TK; Kamp D; Rahman Q; Mossman BT
Free Radic Biol Med; 2003 May; 34(9):1117-29. PubMed ID: 12706492
[TBL] [Abstract][Full Text] [Related]
5. Asbestosis: clinical spectrum and pathogenic mechanisms.
Kamp DW; Weitzman SA
Proc Soc Exp Biol Med; 1997 Jan; 214(1):12-26. PubMed ID: 9012357
[TBL] [Abstract][Full Text] [Related]
6. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences.
Donaldson K; Poland CA; Murphy FA; MacFarlane M; Chernova T; Schinwald A
Adv Drug Deliv Rev; 2013 Dec; 65(15):2078-86. PubMed ID: 23899865
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.
Mossman BT; Lippmann M; Hesterberg TW; Kelsey KT; Barchowsky A; Bonner JC
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):76-121. PubMed ID: 21534086
[TBL] [Abstract][Full Text] [Related]
9. Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response.
Kamp DW; Liu G; Cheresh P; Kim SJ; Mueller A; Lam AP; Trejo H; Williams D; Tulasiram S; Baker M; Ridge K; Chandel NS; Beri R
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):892-901. PubMed ID: 23885834
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular basis of the asbestos-related diseases.
Rom WN; Travis WD; Brody AR
Am Rev Respir Dis; 1991 Feb; 143(2):408-22. PubMed ID: 1990961
[TBL] [Abstract][Full Text] [Related]
11. Asbestos and the lung in the 21st century: an update.
Prazakova S; Thomas PS; Sandrini A; Yates DH
Clin Respir J; 2014 Jan; 8(1):1-10. PubMed ID: 23711077
[TBL] [Abstract][Full Text] [Related]
12. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease.
Solbes E; Harper RW
J Investig Med; 2018 Apr; 66(4):721-727. PubMed ID: 29306869
[TBL] [Abstract][Full Text] [Related]
13. Asbestos-Induced Gastrointestinal Cancer: An Update.
Kim SJ; Williams D; Cheresh P; Kamp DW
J Gastrointest Dig Syst; 2013 Oct; 3(3):. PubMed ID: 27158561
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage.
Kim SJ; Cheresh P; Jablonski RP; Morales-Nebreda L; Cheng Y; Hogan E; Yeldandi A; Chi M; Piseaux R; Ridge K; Michael Hart C; Chandel N; Scott Budinger GR; Kamp DW
Free Radic Biol Med; 2016 Dec; 101():482-490. PubMed ID: 27840320
[TBL] [Abstract][Full Text] [Related]
15. Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals.
Kamp DW; Panduri Va; Weitzman SA; Chandel N
Mol Cell Biochem; 2002; 234-235(1-2):153-60. PubMed ID: 12162428
[TBL] [Abstract][Full Text] [Related]
16. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?
Sanchez VC; Pietruska JR; Miselis NR; Hurt RH; Kane AB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):511-29. PubMed ID: 20049814
[TBL] [Abstract][Full Text] [Related]
17. The role of free radicals in asbestos-induced diseases.
Kamp DW; Graceffa P; Pryor WA; Weitzman SA
Free Radic Biol Med; 1992; 12(4):293-315. PubMed ID: 1577332
[TBL] [Abstract][Full Text] [Related]
18. P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis.
Panduri V; Surapureddi S; Soberanes S; Weitzman SA; Chandel N; Kamp DW
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):443-52. PubMed ID: 16357363
[TBL] [Abstract][Full Text] [Related]
19. Asbestos-related pleuropulmonary diseases: benign and malignant.
Lazarus A; Massoumi A; Hostler J; Hostler DC
Postgrad Med; 2012 May; 124(3):116-30. PubMed ID: 22691906
[TBL] [Abstract][Full Text] [Related]
20. The c-Jun N-terminal kinase signaling pathway mediates chrysotile asbestos-induced alveolar epithelial cell apoptosis.
Li P; Liu T; Kamp DW; Lin Z; Wang Y; Li D; Yang L; He H; Liu G
Mol Med Rep; 2015 May; 11(5):3626-34. PubMed ID: 25530474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
